Abstract
Inactivating mutations in the human patched (PTCH) gene have been identified in both familial and sporadic basal cell carcinomas (BCCs). In some tumors mutations have been detected in both alleles thereby supporting the role of PTCH as a tumor suppressor gene. We have analyzed 22/23 coding exons of PTCH for mutations in 44 sporadic BCCs, and detected 10 novel mutations in nine tumors. In two of the mutant tumors the remaining allele was inactivated by loss of heterozygosity. Five novel PTCH polymorphisms were also identified. Most of the variations found were C>T substitutions at dipyrimidine sites, supporting previous studies which indicate a role for ultraviolet-B in the genesis of sporadic BCCs.
Copyright 2000 Wiley-Liss, Inc.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Alleles
-
Amino Acid Substitution / physiology
-
Arsenic Poisoning / pathology
-
Australia / epidemiology
-
Carcinoma, Basal Cell / ethnology
-
Carcinoma, Basal Cell / genetics*
-
Carcinoma, Basal Cell / pathology
-
DNA Mutational Analysis
-
DNA Primers / chemistry
-
DNA, Neoplasm / genetics
-
Female
-
Genes, Tumor Suppressor
-
Humans
-
Loss of Heterozygosity
-
Male
-
Membrane Proteins / genetics*
-
Molecular Sequence Data
-
Mutation*
-
Patched Receptors
-
Patched-1 Receptor
-
Polymorphism, Genetic
-
Polymorphism, Single-Stranded Conformational
-
Receptors, Cell Surface
-
Skin Neoplasms / ethnology
-
Skin Neoplasms / genetics*
-
Skin Neoplasms / pathology
Substances
-
DNA Primers
-
DNA, Neoplasm
-
Membrane Proteins
-
PTCH1 protein, human
-
Patched Receptors
-
Patched-1 Receptor
-
Receptors, Cell Surface
Associated data
-
GENBANK/U43148
-
GENBANK/U59464